Search results
AI Enhances Readability of Cancer Information for Patients
Medscape· 9 hours agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
How A.I. Is Revolutionizing Drug Development
New York Times· 5 hours agoEvery interaction is recorded, millions and millions each day, generating 50 terabytes of raw data daily — the equivalent of more than 12,000 movies. The...
Pfizer to have 8 'blockbuster' cancer drugs by 2030
Becker’s Hospital Review· 3 days agoPfizer anticipates developing eight or more potential "blockbuster" cancer drugs by 2030. Pfizer anticipates the new drugs will contribute approximately 65% of its oncology ...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 8 hours ago“Previously, there was not an FDA-approved treatment option for NTRK-positive cancers that was...
The Zacks Analyst Blog Highlights Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT
Zacks via Yahoo Finance· 2 hours agoThe company boasts a solid portfolio of core drugs for diabetes, autoimmune diseases and cancer. Its...
Cancer’s Molecular Achilles Heel: Key to Improving Cancer Treatments Discovered
SciTechDaily· 2 days agoResearch at the University of Würzburg aims to refine these inhibitors to target more specifically...
Discovery may explain pancreatic cancer's cellular amnesia
Medical Xpress· 5 hours agoFor years, researchers have wondered exactly how this deadly disease, known as basal-like pancreatic cancer, works. Now, Maia-Silva and colleagues at CSHL have discovered that a protein called MED12 may play a critical role.
Topeka resident shares her story of sexual abuse, PTSD and transitioning to be a woman
The Topeka Capital-Journal via Yahoo News· 22 minutes ago(Boys are) the most boring bunch of people smacking each other and having absolutely no...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 3 days agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 6 days ago:PCSA), a clinical-stage pharmaceutical company, has announced favorable preliminary results from a...
